Earnings Feed
Start Free
|4Nov 3, 7:53 PM ET

ALLERGAN INC 4

4 · ALLERGAN INC · Filed Nov 3, 2003

Insider Transaction Report

Form 4
Period: 2003-10-30
ALLERGAN INC(AGN)
FELLOWS DAVID A
CVP, Pres., EuroAsia/Africa/ME
Transactions
  • Sale

    Common Stock

    2003-10-30$76.06/sh−21,520$1,636,897→ 8,986.41 total
  • Exercise/Conversion

    Common Stock

    2003-10-30$13.01/sh+21,520$279,889→ 30,506.41 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    2003-10-30$76.06/sh−21,520$1,636,897→ 0 total
    Exercise: $13.01Exp: 2007-04-22→ Common Stock (21,520 underlying)
Holdings

  • Common Stock

    (indirect: By Spouse)
    2,314.775

  • Common Stock

    (indirect: By Trust)
    3,497.71

  • Common Stock

    (indirect: By Trust)
    6,332.405
Footnotes (2)
  • [F1]Includes phantom stock units accrued under the Allergan, Inc. Dividend Reinvestment Plan.
  • [F2]Nonqualified stock option granted 4/22/97 under the issuer's incentive compensation plan, which option vested ratably over 4 years from the date of grant.

Documents

1 file
  • 4
    fel223.xmlPrimary